Suppr超能文献

在一项前瞻性加拿大队列研究中,哺乳期妇女使用处方药物和非处方药物的情况。

The use of prescription medications and non-prescription medications during lactation in a prospective Canadian cohort study.

机构信息

Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.

George and Fay Yee Centre for Healthcare Innovation, Winnipeg, MB, Canada.

出版信息

Int Breastfeed J. 2024 Apr 8;19(1):23. doi: 10.1186/s13006-024-00628-x.

Abstract

BACKGROUND

A lack of safety data on postpartum medication use presents a potential barrier to breastfeeding and may result in infant exposure to medications in breastmilk. The type and extent of medication use by lactating women requires investigation.

METHODS

Data were collected from the CHILD Cohort Study which enrolled pregnant women across Canada between 2008 and 2012. Participants completed questionnaires regarding medications and non-prescription medications used and breastfeeding status at 3, 6 and 12 months postpartum. Medications, along with self-reported reasons for medication use, were categorized by ontologies [hierarchical controlled vocabulary] as part of a large-scale curation effort to enable more robust investigations of reasons for medication use.

RESULTS

A total of 3542 mother-infant dyads were recruited to the CHILD study. Breastfeeding rates were 87.4%, 75.3%, 45.5% at 3, 6 and 12 months respectively. About 40% of women who were breastfeeding at 3 months used at least one prescription medication during the first three months postpartum; this proportion decreased over time to 29.5% % at 6 months and 32.8% at 12 months. The most commonly used prescription medication by breastfeeding women was domperidone at 3 months (9.0%, n = 229/2540) and 6 months (5.6%, n = 109/1948), and norethisterone at 12 months (4.1%, n = 48/1180). The vast majority of domperidone use by breastfeeding women (97.3%) was for lactation purposes which is off-label (signifying unapproved use of an approved medication). Non-prescription medications were more often used among breastfeeding than non-breastfeeding women (67.6% versus 48.9% at 3 months, p < 0.0001), The most commonly used non-prescription medications were multivitamins and Vitamin D at 3, 6 and 12 months postpartum.

CONCLUSIONS

In Canada, medication use is common postpartum; 40% of breastfeeding women use prescription medications in the first 3 months postpartum. A diverse range of medications were used, with many women taking more than one prescription and non-prescription medicines. The most commonly used prescription medication by breastfeeding women were domperidone for off-label lactation support, signalling a need for more data on the efficacy of domperidone for this indication. This data should inform research priorities and communication strategies developed to optimize care during lactation.

摘要

背景

产后用药的安全性数据不足,这可能会对母乳喂养造成阻碍,并导致婴儿在母乳中接触到药物。因此,有必要对哺乳期妇女的用药类型和程度进行调查。

方法

本研究的数据来自于 2008 年至 2012 年间在加拿大开展的儿童队列研究。研究招募了怀孕的女性,参与者在产后 3、6 和 12 个月时通过问卷的形式报告了用药和非处方用药情况以及母乳喂养状态。药物和自我报告的用药原因按照本体论[分层控制词汇]进行分类,这是一项大规模策展工作的一部分,旨在促进对用药原因的更深入研究。

结果

共有 3542 对母婴对被纳入到儿童队列研究中。产后 3、6 和 12 个月时,母乳喂养率分别为 87.4%、75.3%和 45.5%。约 40%的产后 3 个月的母乳喂养女性在产后前三个月至少使用了一种处方药;这一比例随着时间的推移逐渐下降,6 个月时降至 29.5%,12 个月时降至 32.8%。产后 3 个月和 6 个月时,最常被母乳喂养女性使用的处方药是多潘立酮(9.0%,n=229/2540 和 5.6%,n=109/1948),产后 12 个月时是炔诺酮(4.1%,n=48/1180)。绝大多数哺乳期女性使用多潘立酮(97.3%)是出于哺乳期用途,属于超说明书(表示批准的药物的未经批准的使用)。与非母乳喂养女性相比,母乳喂养女性更常使用非处方药(产后 3 个月时为 67.6%和 48.9%,p<0.0001)。最常使用的非处方药是多种维生素和维生素 D,产后 3、6 和 12 个月时均有使用。

结论

在加拿大,产后用药很常见;40%的母乳喂养女性在产后前 3 个月使用处方药。使用的药物种类繁多,许多女性同时使用一种以上的处方药和非处方药。母乳喂养女性最常使用的处方药是多潘立酮,用于未经批准的哺乳期支持,表明需要更多关于多潘立酮在该适应症下的疗效数据。这些数据应作为信息来源,为优化哺乳期护理而制定研究重点和沟通策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60db/11000278/e88e889ea792/13006_2024_628_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验